ATKR vs XMTR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant deterioration in fundamental performance. Despite a strong Current Ratio and manageable Debt/Equity, the company is unprofitable on a net basis (Profit Margin: -0.53%, ROE: -1.03%) and facing sharp earnings contraction (YoY EPS Growth: -71.6%). Valuation appears stretched relative to peers with a Forward P/E of 12.23 while operating in a declining revenue environment (Revenue Growth YoY: -4.60%), and the lack of a Graham Number or Altman Z-Score limits confidence in intrinsic value and solvency safety. Although the dividend yield is modestly attractive at 1.80% with a sustainable payout ratio, weak earnings momentum, deteriorating profitability, and neutral insider activity suggest substantial downside risks.
XMTR presents a classic growth-stage profile with a critical divergence between operational momentum and financial health. The Piotroski F-Score of 2/9 indicates significant fundamental weakness, yet the company has successfully pivoted toward profitability with a 166.7% YoY EPS growth and consistent earnings beats. While revenue growth remains strong at 29.5%, the bearish insider sentiment and high Price-to-Book ratio suggest the current valuation may be ahead of the underlying financial stability.
Compare Another Pair
Related Comparisons
ATKR vs XMTR: Head-to-Head Comparison
This page compares Atkore Inc. (ATKR) and Xometry, Inc. (XMTR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.